Mirza v. Orange Reg'l Med. Ctr.

CourtCourt of Appeals for the Second Circuit
DecidedJune 18, 2024
Docket22-815
StatusUnpublished

This text of Mirza v. Orange Reg'l Med. Ctr. (Mirza v. Orange Reg'l Med. Ctr.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mirza v. Orange Reg'l Med. Ctr., (2d Cir. 2024).

Opinion

22-815-cv Mirza v. Orange Reg’l Med. Ctr.

UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT

SUMMARY ORDER

RULINGS BY SUMMARY ORDER DO NOT HAVE PRECEDENTIAL EFFECT. CITATION TO A SUMMARY ORDER FILED ON OR AFTER JANUARY 1, 2007, IS PERMITTED AND IS GOVERNED BY FEDERAL RULE OF APPELLATE PROCEDURE 32.1 AND THIS COURT’S LOCAL RULE 32.1.1. WHEN CITING A SUMMARY ORDER IN A DOCUMENT FILED WITH THIS COURT, A PARTY MUST CITE EITHER THE FEDERAL APPENDIX OR AN ELECTRONIC DATABASE (WITH THE NOTATION “SUMMARY ORDER”). A PARTY CITING TO A SUMMARY ORDER MUST SERVE A COPY OF IT ON ANY PARTY NOT REPRESENTED BY COUNSEL.

At a stated term of the United States Court of Appeals for the Second Circuit, held at the Thurgood Marshall United States Courthouse, 40 Foley Square, in the City of New York, on the 18th day of June, two thousand twenty-four.

PRESENT: DENNIS JACOBS, EUNICE C. LEE, SARAH A. L. MERRIAM, Circuit Judges. _____________________________________

Tahira F. Mirza,

Plaintiff-Appellant,

v. 22-815-cv

Orange Regional Medical Center; Garnet Health, FKA Greater Hudson Valley Health System, Inc.; Dr. Gerard Galarneau; Jerry Dunlavey, MBA; James Oxley; Dr. Mohammad Siddiqui; Garnet Health Doctors, P.C., FKA GHVHS Medical Group, P.C.; Garnet Health Medical Center, FKA Orange Regional Medical Center,

Defendants-Appellees. _____________________________________ FOR PLAINTIFF-APPELLANT: TAHIRA F. MIRZA, pro se, Hartford, CT.

FOR DEFENDANTS-APPELLEES: JOSEPH A. SACCOMANO, JR., Jackson Lewis P.C., White Plains, NY.

Appeal from a judgment of the United States District Court for the Southern District of

New York (Philip M. Halpern, Judge).

UPON DUE CONSIDERATION, IT IS HEREBY ORDERED, ADJUDGED, AND

DECREED that the judgment of the district court is AFFIRMED.

* * *

Dr. Tahira Mirza, now proceeding pro se, brought a lawsuit against her former employer

and associated individuals and entities, claiming primarily that she had been the victim of unlawful

retaliation in violation of the federal and New York False Claims Acts (“FCA”), 31 U.S.C.

§ 3730(h) and N.Y. State Fin. Law § 191(1), for objecting to “upcoding” billing practices that, in

her view, constituted Medicare and Medicaid Fraud. Mirza’s counseled operative complaint also

contained a variety of other New York common law and statutory claims. For instance, she

brought a claim under New York’s health care whistleblower law, N.Y. Lab. Law § 741, as well

as a claim for retaliatory defamation related to a reference letter recommending Mirza “with

reservations.”

After denying two of her motions to compel discovery and declining to vacate or modify a

confidentiality stipulation, the district court granted the defendants’ motion for summary

2 judgment. The district court concluded that Mirza had not demonstrated a prima facie FCA claim

because the record did not show activity protected by the FCA, an adverse action, or but-for

causation. See Mirza v. Garnet Health, No. 20-CV-00556 (PMH), 2022 WL 826410, at *9–13

(S.D.N.Y. Mar. 17, 2022). The district court held that Mirza’s other state law claims failed

because, among other things, she had failed to identify a law relating to patient care that the

defendants allegedly violated, and because a broad release she had signed immunized the

defendants from liability in connection with the allegedly defamatory reference statement. See

id. at *13–16. Mirza appealed. We assume the parties’ familiarity with the remainder of the

underlying facts, the procedural history, and the issues on appeal, to which we refer only as

necessary to explain our decision to affirm.

I. Discovery and Confidentiality Stipulation

We review the denial of a motion to compel discovery for abuse of discretion. See In re

650 Fifth Ave. and Related Props., 934 F.3d 147, 156 (2d Cir. 2019). A district court abuses its

discretion in this context “only when the discovery is so limited as to affect a party’s substantial

rights.” Clark v. Hanley, 89 F.4th 78, 91 (2d Cir. 2023) (quoting In re Agent Orange Prod. Liab.

Litig., 517 F.3d 76, 103 (2d Cir. 2008)). We also review a decision declining “to vacate or modify

a protective order for abuse of discretion.” Gambale v. Deutsche Bank AG, 377 F.3d 133, 139

(2d Cir. 2004).

The district court did not abuse its discretion in issuing the challenged orders. Mirza fails

to explain how her substantial rights were violated by the district court’s decision denying her

motions to compel. Regarding the stipulation, a court generally should not modify a protective

3 order when a party has reasonably relied on it, absent extraordinary circumstances or a compelling

need. See S.E.C. v. TheStreet.com, 273 F.3d 222, 229 (2d Cir. 2001). Here, the defendants

provided discovery in reliance on the confidentiality stipulation, and Mirza has not met her burden

of showing extraordinary circumstances or a compelling need to vacate or modify it. 1

II. Summary Judgment

We review the summary judgment decision de novo, viewing the record and drawing all

reasonable inferences in Mirza’s favor. See Sotomayor v. City of New York, 713 F.3d 163, 164

(2d Cir. 2013) (per curiam). “Summary judgment is appropriate only when ‘there is no genuine

dispute as to any material fact and the movant is entitled to judgment as a matter of law.’” Id.

(quoting Fed. R. Civ. P. 56(a)).

The district court concluded that Mirza’s FCA claims failed due in part to a lack of evidence

showing a causal connection between the protected activity and adverse actions. Mirza has not

addressed the district court’s holding on this point and references causation only in passing on

appeal. Causation—a showing that an adverse action was taken because an employee engaged in

a protected activity—is a necessary element of an FCA retaliation claim under both federal and

state law. See United States ex rel. Chorches for Bankr. Est. of Fabula v. Am. Med. Response,

Inc., 865 F.3d 71, 95 (2d Cir. 2017); see also Comptroller of City of N.Y. v. Bank of N.Y. Mellon

1 Mirza also raises arguments relating to the district court’s management of the summary judgment process; for instance, she contends that the district court erred in striking her re-filed opposition papers as an unauthorized sur- reply. A review of the challenged rulings reveals no abuse of the district court’s considerable discretion to direct and manage its docket. See In re World Trade Ctr. Disaster Site Litig., 722 F.3d 483, 487 (2d Cir. 2013) (emphasizing the “particular deference” we afford to a district court in reviewing its discretionary determinations for orderly and expeditious litigation management).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sotomayor v. City of New York
713 F.3d 163 (Second Circuit, 2013)
Gerstenbluth v. Credit Suisse Securities (USA) LLC
728 F.3d 139 (Second Circuit, 2013)
In Re Agent Orange" Product Liability Litigation
517 F.3d 76 (Second Circuit, 2008)
Kwan v. The Andalex Group LLC
737 F.3d 834 (Second Circuit, 2013)
In re 650 Fifth Ave. & Related Props.
934 F.3d 147 (Second Circuit, 2019)
Cortez v. City of New York
722 F.3d 483 (Second Circuit, 2013)
Vega v. Hempstead Union Free School District
801 F.3d 72 (Second Circuit, 2015)
Clark v. Hanley
89 F.4th 78 (Second Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Mirza v. Orange Reg'l Med. Ctr., Counsel Stack Legal Research, https://law.counselstack.com/opinion/mirza-v-orange-regl-med-ctr-ca2-2024.